The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the […]
An emerging nanomedicine cancer treatment involving the injection of tiny nanoparticles carrying compounds that can poison cancerous cells has many benefits. This so-called photodynamic therapy (PDT) […]